wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q37824258-093B1B52-B7F0-4CDC-974D-5B83656FF895
Q37824258-093B1B52-B7F0-4CDC-974D-5B83656FF895
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37824258-093B1B52-B7F0-4CDC-974D-5B83656FF895
Review of Y-ibritumomab tiuxetan as first-line consolidation radio-immunotherapy for B-cell follicular non-Hodgkin's lymphoma.
P2860
Q37824258-093B1B52-B7F0-4CDC-974D-5B83656FF895
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37824258-093B1B52-B7F0-4CDC-974D-5B83656FF895
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
39f771749d2a43659cb5fd084d99595ca579ceb7
P2860
Fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in previously untreated patients with follicular non-Hodgkin lymphoma trial: a phase II non-randomised trial (FLUMIZ).